๐
Pelmeg
pegfilgrastim
โ
Authorised
Biosimilar
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
To reduce the duration of neutropenia and the incidence of febrile neutropenia due to chemotherapy.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/pelmeg